DRUG STUDY

Prepared by:
Sunga, Katrina Andrea

FEU-NRMF
BSN-4C
 Nursing
Generic Name Dosag Classification Indication Contraindication Side-effect Responsibility
e

>Metoclopromi 10 GIT Regulators, Nausea and GI haemorrhage, Extrapyramidal Special

de mg Antiflatulents & vomiting mechanical symptoms, precaution on
TIV Anti- associated w/ obstruction and restlessness, pregnancy
q8’ inflammatories, cancer perforation; drowsiness, anxiety, and lactation.
Antiemetics chemotherapy phaeochromocytoma; diarrhoea, Monitor
See available or history of seizures. hypotension, patients on
brands of radiotherapy; hypertension, prolonged
metoclopramide Gastro- headache, depression therapy.
oesophageal Potentially Fatal: Increased risk
reflux disease Neuroleptic malignant of tardive
10-15 mg up syndrome; cardiac dyskinesia in
to 4 conduction disorders patients on
times/day, may occur with IV prolonged or
depending on dosage form. high-dose
severity of treatment.
symptoms.
Delayed
emesis
following
chemotherapy
•Constipation
is often
severe with
Hypersensitivity to maintenance
nalbuphine and or therapy. Make
> Nalbuphine 5mg Moderate to bisulfates. Patients CNS: dizziness, sure stool
TIV q severe pain. who are physically headache, sedation, softener or
6 x4 Also provides: dependent on opioids confusion, dysphoria, other laxative
dose Analgesia and have not been euphoria, floating is ordered.
then during labor, detoxified. feeling, •
PRN sedation hallucinations, Psychological
before unusual dreams. and physical
surgery, and EENT: blurred vision, dependence
supplement to diplopia, miosis (high may occur
balanced doses) Resp: with
anesthesia. respiratory prolonged
depression CV: use.
hypertension, • Remind
orthostatic, patient not to
hypotension, confuse
palpitations GI: dry Nubain with
mouth, nausea, Navane.
vomiting,